Global Advance Directives 麻豆原创 Growth (Status and Outlook) 2025-2031

Publication ID:

LPI06254084

Publication Date:

June 20, 2025

Pages:

129

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Advance Directives market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Advance Directives is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Advance Directives is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Advance Directives is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Advance Directives players cover ADvault, VyncaCare, WiserCareInc, Sharp HealthCare, ACP Decisions, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淎dvance Directives Industry Forecast鈥� looks at past sales and reviews total world Advance Directives sales in 2024, providing a comprehensive analysis by region and market sector of projected Advance Directives sales for 2025 through 2031. With Advance Directives sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Advance Directives industry.
This Insight Report provides a comprehensive analysis of the global Advance Directives landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Advance Directives portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Advance Directives market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Advance Directives and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Advance Directives.
This report presents a comprehensive overview, market shares, and growth opportunities of Advance Directives market by product type, application, key players and key regions and countries.
Segmentation by Type:
Software
Service
Segmentation by Application:
Child
Adult
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
ADvault
VyncaCare
WiserCareInc
Sharp HealthCare
ACP Decisions
lris
Healthcare
Bronson Health Care Group
Koda Health
ThroughCare
Vital Decisions
Affirm Health
MIDEO
New Century Health
Thanacare
Island Health
Honor My Decisions LLC

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Advance Directives 麻豆原创 Size (2020-2031)
2.1.2 Advance Directives 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Advance Directives by Country/Region (2020, 2024 & 2031)
2.2 Advance Directives Segment by Type
2.2.1 Software
2.2.2 Service
2.3 Advance Directives 麻豆原创 Size by Type
2.3.1 Advance Directives 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Advance Directives 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Advance Directives Segment by Application
2.4.1 Child
2.4.2 Adult
2.5 Advance Directives 麻豆原创 Size by Application
2.5.1 Advance Directives 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Advance Directives 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Advance Directives 麻豆原创 Size by Player
3.1 Advance Directives 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Advance Directives Revenue by Player (2020-2025)
3.1.2 Global Advance Directives Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Advance Directives Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Advance Directives by Region
4.1 Advance Directives 麻豆原创 Size by Region (2020-2025)
4.2 Global Advance Directives Annual Revenue by Country/Region (2020-2025)
4.3 Americas Advance Directives 麻豆原创 Size Growth (2020-2025)
4.4 APAC Advance Directives 麻豆原创 Size Growth (2020-2025)
4.5 Europe Advance Directives 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Advance Directives 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Advance Directives 麻豆原创 Size by Country (2020-2025)
5.2 Americas Advance Directives 麻豆原创 Size by Type (2020-2025)
5.3 Americas Advance Directives 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Advance Directives 麻豆原创 Size by Region (2020-2025)
6.2 APAC Advance Directives 麻豆原创 Size by Type (2020-2025)
6.3 APAC Advance Directives 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Advance Directives 麻豆原创 Size by Country (2020-2025)
7.2 Europe Advance Directives 麻豆原创 Size by Type (2020-2025)
7.3 Europe Advance Directives 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Advance Directives by Region (2020-2025)
8.2 Middle East & Africa Advance Directives 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Advance Directives 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Advance Directives 麻豆原创 Forecast
10.1 Global Advance Directives Forecast by Region (2026-2031)
10.1.1 Global Advance Directives Forecast by Region (2026-2031)
10.1.2 Americas Advance Directives Forecast
10.1.3 APAC Advance Directives Forecast
10.1.4 Europe Advance Directives Forecast
10.1.5 Middle East & Africa Advance Directives Forecast
10.2 Americas Advance Directives Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Advance Directives Forecast
10.2.2 Canada 麻豆原创 Advance Directives Forecast
10.2.3 Mexico 麻豆原创 Advance Directives Forecast
10.2.4 Brazil 麻豆原创 Advance Directives Forecast
10.3 APAC Advance Directives Forecast by Region (2026-2031)
10.3.1 China Advance Directives 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Advance Directives Forecast
10.3.3 Korea 麻豆原创 Advance Directives Forecast
10.3.4 Southeast Asia 麻豆原创 Advance Directives Forecast
10.3.5 India 麻豆原创 Advance Directives Forecast
10.3.6 Australia 麻豆原创 Advance Directives Forecast
10.4 Europe Advance Directives Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Advance Directives Forecast
10.4.2 France 麻豆原创 Advance Directives Forecast
10.4.3 UK 麻豆原创 Advance Directives Forecast
10.4.4 Italy 麻豆原创 Advance Directives Forecast
10.4.5 Russia 麻豆原创 Advance Directives Forecast
10.5 Middle East & Africa Advance Directives Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Advance Directives Forecast
10.5.2 South Africa 麻豆原创 Advance Directives Forecast
10.5.3 Israel 麻豆原创 Advance Directives Forecast
10.5.4 Turkey 麻豆原创 Advance Directives Forecast
10.6 Global Advance Directives Forecast by Type (2026-2031)
10.7 Global Advance Directives Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Advance Directives Forecast
11 Key Players Analysis
11.1 ADvault
11.1.1 ADvault Company Information
11.1.2 ADvault Advance Directives Product Offered
11.1.3 ADvault Advance Directives Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 ADvault Main Business Overview
11.1.5 ADvault Latest Developments
11.2 VyncaCare
11.2.1 VyncaCare Company Information
11.2.2 VyncaCare Advance Directives Product Offered
11.2.3 VyncaCare Advance Directives Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 VyncaCare Main Business Overview
11.2.5 VyncaCare Latest Developments
11.3 WiserCareInc
11.3.1 WiserCareInc Company Information
11.3.2 WiserCareInc Advance Directives Product Offered
11.3.3 WiserCareInc Advance Directives Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 WiserCareInc Main Business Overview
11.3.5 WiserCareInc Latest Developments
11.4 Sharp HealthCare
11.4.1 Sharp HealthCare Company Information
11.4.2 Sharp HealthCare Advance Directives Product Offered
11.4.3 Sharp HealthCare Advance Directives Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Sharp HealthCare Main Business Overview
11.4.5 Sharp HealthCare Latest Developments
11.5 ACP Decisions
11.5.1 ACP Decisions Company Information
11.5.2 ACP Decisions Advance Directives Product Offered
11.5.3 ACP Decisions Advance Directives Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 ACP Decisions Main Business Overview
11.5.5 ACP Decisions Latest Developments
11.6 lris
11.6.1 lris Company Information
11.6.2 lris Advance Directives Product Offered
11.6.3 lris Advance Directives Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 lris Main Business Overview
11.6.5 lris Latest Developments
11.7 Healthcare
11.7.1 Healthcare Company Information
11.7.2 Healthcare Advance Directives Product Offered
11.7.3 Healthcare Advance Directives Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 Healthcare Main Business Overview
11.7.5 Healthcare Latest Developments
11.8 Bronson Health Care Group
11.8.1 Bronson Health Care Group Company Information
11.8.2 Bronson Health Care Group Advance Directives Product Offered
11.8.3 Bronson Health Care Group Advance Directives Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 Bronson Health Care Group Main Business Overview
11.8.5 Bronson Health Care Group Latest Developments
11.9 Koda Health
11.9.1 Koda Health Company Information
11.9.2 Koda Health Advance Directives Product Offered
11.9.3 Koda Health Advance Directives Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 Koda Health Main Business Overview
11.9.5 Koda Health Latest Developments
11.10 ThroughCare
11.10.1 ThroughCare Company Information
11.10.2 ThroughCare Advance Directives Product Offered
11.10.3 ThroughCare Advance Directives Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 ThroughCare Main Business Overview
11.10.5 ThroughCare Latest Developments
11.11 Vital Decisions
11.11.1 Vital Decisions Company Information
11.11.2 Vital Decisions Advance Directives Product Offered
11.11.3 Vital Decisions Advance Directives Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 Vital Decisions Main Business Overview
11.11.5 Vital Decisions Latest Developments
11.12 Affirm Health
11.12.1 Affirm Health Company Information
11.12.2 Affirm Health Advance Directives Product Offered
11.12.3 Affirm Health Advance Directives Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.12.4 Affirm Health Main Business Overview
11.12.5 Affirm Health Latest Developments
11.13 MIDEO
11.13.1 MIDEO Company Information
11.13.2 MIDEO Advance Directives Product Offered
11.13.3 MIDEO Advance Directives Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.13.4 MIDEO Main Business Overview
11.13.5 MIDEO Latest Developments
11.14 New Century Health
11.14.1 New Century Health Company Information
11.14.2 New Century Health Advance Directives Product Offered
11.14.3 New Century Health Advance Directives Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.14.4 New Century Health Main Business Overview
11.14.5 New Century Health Latest Developments
11.15 Thanacare
11.15.1 Thanacare Company Information
11.15.2 Thanacare Advance Directives Product Offered
11.15.3 Thanacare Advance Directives Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.15.4 Thanacare Main Business Overview
11.15.5 Thanacare Latest Developments
11.16 Island Health
11.16.1 Island Health Company Information
11.16.2 Island Health Advance Directives Product Offered
11.16.3 Island Health Advance Directives Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.16.4 Island Health Main Business Overview
11.16.5 Island Health Latest Developments
11.17 Honor My Decisions LLC
11.17.1 Honor My Decisions LLC Company Information
11.17.2 Honor My Decisions LLC Advance Directives Product Offered
11.17.3 Honor My Decisions LLC Advance Directives Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.17.4 Honor My Decisions LLC Main Business Overview
11.17.5 Honor My Decisions LLC Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.